FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 161 of 161

PHARMACEUTICAL PREPARATIONS - SIC # 2834

Ticker Exchange Company Financial Reports SIC #
VIRX Nasdaq Viracta Therapeutics, Inc. 2834
VRCA Nasdaq Verrica Pharmaceuticals Inc. 2834
VTYX Nasdaq Ventyx Biosciences, Inc. 2834
VYNE Nasdaq VYNE Therapeutics Inc. 2834
WALD Nasdaq Waldencast plc 2834
XERS Nasdaq Xeris Biopharma Holdings, Inc. 2834
XRTX Nasdaq XORTX Therapeutics Inc. 2834
YCBD NYSE American cbdMD, Inc. 2834
ZVRA Nasdaq Zevra Therapeutics, Inc. 2834
ZVSA Nasdaq ZyVersa Therapeutics, Inc. 2834
ZYME Nasdaq Zymeworks Inc. 2834
Results 150 through 161 of 161